Daniel Morgado-Carrasco
Overview
Explore the profile of Daniel Morgado-Carrasco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gil-Lianes J, Gil-Lianes J, Marti-Marti I, Marti-Marti I, Morgado-Carrasco D, Morgado-Carrasco D
Actas Dermosifiliogr
. 2025 Feb;
PMID: 39988199
Although secondary intention healing (SIH) is a fundamental aspect of postoperative care following Mohs micrographic ssurgery (MMS), it is currently underutilized. SIH constitutes a safe, cost-effective, and versatile method for...
2.
Piquero-Casals J, Saceda-Corralo D, Aladren S, Bustos J, Fernandez-Botello A, Navasa A, et al.
Skin Appendage Disord
. 2025 Feb;
11(1):27-35.
PMID: 39911983
Introduction: Chronic telogen effluvium (TE) and androgenetic alopecia represent two prevalent forms of hair loss that can significantly impact individuals' quality of life. Insufficiency of essential micronutrients has been associated...
3.
Gil-Lianes J, Gil-Lianes J, Marti-Marti I, Marti-Marti I, Morgado-Carrasco D, Morgado-Carrasco D
Actas Dermosifiliogr
. 2025 Jan;
PMID: 39755147
No abstract available.
4.
Morgado-Carrasco D, Delgado J, Prudkin-Silva L, Santamaria J, Piquero-Casals J
Photodermatol Photoimmunol Photomed
. 2024 Aug;
40(5):e12996.
PMID: 39149878
Background: Dark-skinned individuals (DSI) present high rates of melasma and post-inflammatory hyperpigmentation. The use of sunscreens with mineral filters is essential for prevention and treatment. Our objective was to determine...
5.
Mansilla-Polo M, Morgado-Carrasco D
Rev Esp Geriatr Gerontol
. 2024 Jul;
59(6):101535.
PMID: 39053083
No abstract available.
6.
Mansilla-Polo M, Morgado-Carrasco D
Dermatol Ther (Heidelb)
. 2024 Jul;
14(8):1983-2038.
PMID: 39014279
Introduction: The risk of infections associated with biological drugs (BD) and Janus kinase inhibitors (JAKi) has been extensively explored in the literature. However, there is a dearth of studies that...
7.
Mansilla-Polo M, Morgado-Carrasco D
JAMA Dermatol
. 2024 Jun;
160(8):887.
PMID: 38888916
No abstract available.
8.
Mansilla-Polo M, Morgado-Carrasco D
Dermatol Ther (Heidelb)
. 2024 May;
14(6):1389-1442.
PMID: 38763966
Introduction: Biological drugs (BD) and Janus kinase inhibitors (JAKi) have revolutionized the treatment of diverse dermatoses. However, there are concerns regarding their safety, especially the risk of cancer and opportunistic...
9.
Gil-Lianes J, Luque-Luna M, Morgado-Carrasco D
J Dtsch Dermatol Ges
. 2024 Apr;
22(6):837-838.
PMID: 38613522
No abstract available.
10.
Mansilla-Polo M, Morgado-Carrasco D, Toll A
Indian J Dermatol Venereol Leprol
. 2024 Apr;
:1-3.
PMID: 38594977
No abstract available.